Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2019 Dec 5;7(1):e657. doi: 10.1212/NXI.0000000000000657

A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS

PMCID: PMC6935840  PMID: 31806686

In the Clinical/Scientific Note “A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS” by Rolfes et al.,1 first published online November 8, 2019, the label in figure 1F should read “Abdominal CT scan outlining extensive abdominal (yellow arrows) and inguinal (red arrows) lymphadenopathy.” The authors regret the error.

Reference

  • 1.Rolfes L, Pfeuffer S, Ruck T, et al. A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS. Neurol Neuroimmunol Neuroinflamm 2020;7:e638. doi: 10.1212/NXI.0000000000000638. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES